Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104


Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression.

Karanevich AG, Statland JM, Gajewski BJ, He J.

BMC Med Res Methodol. 2018 Feb 6;18(1):19. doi: 10.1186/s12874-018-0479-9.


A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.

Daghlas I, Lever TE, Leary E.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):206-211. doi: 10.1080/21678421.2017.1418001. Epub 2017 Dec 20.


Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database.

Bacci ED, Staniewska D, Coyne KS, Boyer S, White LA, Zach N, Cedarbaum JM; Pooled Resource Open-Access ALS Clinical Trials Consortium.

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):157-67. doi: 10.3109/21678421.2015.1095930. Epub 2015 Oct 16.


Amyotrophic lateral sclerosis disease progression model.

Gomeni R, Fava M; Pooled Resource Open-Access ALS Clinical Trials Consortium.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):119-29. doi: 10.3109/21678421.2013.838970. Epub 2013 Sep 26.


The PRO-ACT database: design, initial analyses, and predictive features.

Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, Walker J, Katsovskiy I, Schoenfeld D, Cudkowicz M, Leitner M.

Neurology. 2014 Nov 4;83(19):1719-25. doi: 10.1212/WNL.0000000000000951. Epub 2014 Oct 8.


Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.

Tang M, Gao C, Goutman SA, Kalinin A, Mukherjee B, Guan Y, Dinov ID.

Neuroinformatics. 2018 Nov 20. doi: 10.1007/s12021-018-9406-9. [Epub ahead of print]


How common are ALS plateaus and reversals?

Bedlack RS, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R, Macklin EA, Schoenfeld D, Cudkowicz M, Sherman A.

Neurology. 2016 Mar 1;86(9):808-12. doi: 10.1212/WNL.0000000000002251. Epub 2015 Dec 9.


Predicting functional decline and survival in amyotrophic lateral sclerosis.

Ong ML, Tan PF, Holbrook JD.

PLoS One. 2017 Apr 13;12(4):e0174925. doi: 10.1371/journal.pone.0174925. eCollection 2017.


RandomForest4Life: a Random Forest for predicting ALS disease progression.

Hothorn T, Jung HH.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):444-52. doi: 10.3109/21678421.2014.893361.


The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.

Lo Coco D, Marchese S, La Bella V, Piccoli T, Lo Coco A.

Chest. 2007 Jul;132(1):64-9. Epub 2007 May 2.


Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?

Zach N, Ennist DL, Taylor AA, Alon H, Sherman A, Kueffner R, Walker J, Sinani E, Katsovskiy I, Cudkowicz M, Leitner ML.

Neurotherapeutics. 2015 Apr;12(2):417-23. doi: 10.1007/s13311-015-0336-z. Review.


Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.

Hamidou B, Marin B, Lautrette G, Nicol M, Camu W, Corcia P, Arnes-Bes MC, Tranchant C, Clavelou P, Hannequin D, Maurice G, Beauvais K, Antoine JC, Danel-Brunaud V, Viader F, Preux PM, Couratier P.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):519-527. doi: 10.1080/21678421.2017.1353098. Epub 2017 Aug 1.


[Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].

Liu XX, Fan DS, Zhang J, Zhang S, Zheng JY.

Zhonghua Yi Xue Za Zhi. 2009 Sep 22;89(35):2472-5. Chinese.


The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset.

Proudfoot M, Jones A, Talbot K, Al-Chalabi A, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):414-25. doi: 10.3109/21678421.2016.1140786. Epub 2016 Feb 11.


Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.

Lunetta C, Lizio A, Melazzini MG, Maestri E, Sansone VA.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):93-100. doi: 10.3109/21678421.2015.1083585. Epub 2015 Oct 16.


[The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].

Kimura F, Shinoda K, Fujiwara S, Fujimura C, Nakajima H, Furutama D, Sugino M, Hanafusa T.

Rinsho Shinkeigaku. 2003 Jul;43(7):385-91. Japanese.


Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosis.

Jahandideh S, Taylor AA, Beaulieu D, Keymer M, Meng L, Bian A, Atassi N, Andrews J, Ennist DL.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):294-302. doi: 10.1080/21678421.2017.1418003. Epub 2017 Dec 20.


Prognostic factors for the course of functional status of patients with ALS: a systematic review.

Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A.

J Neurol. 2015 Jun;262(6):1407-23. doi: 10.1007/s00415-014-7564-8. Epub 2014 Nov 11. Review.


Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.

Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Körner S, Ringer TM, Rödiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chiò A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH.

Lancet Neurol. 2018 May;17(5):423-433. doi: 10.1016/S1474-4422(18)30089-9. Epub 2018 Mar 26.

Supplemental Content

Support Center